Protein Expression Market worth $1,396.68 Million by 2018
DALLAS, April 24, 2014 /PRNewswire/ –
According to the new market research report “Protein Expression Market by Products
(Expression Vector, Service, Reagent), Expression Systems (Mammalian, Prokaryotic,
Baculovirus, Yeast), Application (Industrial, Therapeutic), End User (Pharmaceutical,
Biotechnology, CRO) – Global Forecast to 2018″ published by MarketsandMarkets, The global
Protein Expression Market is expected to grow at a CAGR of 8.83% between 2013 and 2018, to
reach $1,396.68 Million by 2018..
Browse 111 Market Data Tables and 36 Figures spread through 280 Pages and in-depth TOC
on “Protein Expression Market”.
Early buyers will receive 10% customization on this report.
The report segments this market by expression systems, products, applications, and end
users. The expression system segment includes insect, mammalian, prokaryotic, yeast, and
others. Of these, the prokaryotic segment commanded the largest share of the global
protein expression market, by expression in 2013. The use of E.coli as the preferred host
cell for large quant ity and cheap protein expression and production has accounted for the
highest share of prokaryotic expression systems. The mammalian segment is poised to grow
at the highest CAGR between 2013 and 2018. With the rise in demand for therapeutic
proteins, the need for proteins with appropriate post-translational modifications will
increase, thus driving the speedy growth of the mammalian expression systems.
The product segments included in this report are competent cells, expression vectors,
instruments, reagents, and services. The reagents segment commanded the largest share of
the global protein expression market in 2013, while the services segment is poised to grow
at the highest CAGR between 2013 and 2018. Since chemical transfection is easier and less
expensive, chemical reagents are used for transfections and maintenance of cell lines in
large numbers. Also, the large numbers of reagents in the markets is because the
consumption of reagents is a recurring event as opposed to the relatively less consumption
of vectors and competent host cells. As companies have now started to offer services that
provide custom optimization of protein expression, emerging research labs and companies
who lack resources and expertise will be highly benefitted. Since the protein expression
market is expected to grow at a CAGR of 8.83% between 2013 and 2018, the increasing need
for protein expression will boost the growth of the services offered by companies.
The applications segment of the protein expression market includes industrial
proteins, research applications, and therapeutic proteins. Of these, therapeutic proteins
segment commanded the largest share of the global protein expression market in 2013 and is
also poised to grow at the highest CAGR between 2013 and 2018. Therapeutic proteins serve
a highly specific and complex set of functions that cannot be mimicked by simple chemical
compound. Therapeutic proteins have higher immuntolerance and are ideally suited
therapeutic candidates. Owing to the versatile advantages of therapeutic proteins over
small molecule drugs to alleviate diseases, the therapeutic proteins application of
protein expression is expected to continue growing at the highest CAGR.
The end-user segments included in this report are academic research, contract research
organizations, pharmaceutical and biotechnological companies, and others. Of these, the
pharmaceutical and biotechnological companies segment commanded the largest share of the
global protein expression market in 2013, while the contract research organizations
segment is poised to grow at the highest CAGR between 2013 and 2018. Protein expression
finds primary application in the research and development of commercial proteins for use
in pharmaceuticals and biotechnology. As such, pharmaceutical and biotechnological
companies hold the highest share of global protein expression market. With the increasing
outsourcing by pharmaceutical and biotechnological companies and the lack of resources and
expertise in the emerging pharmaceutical companies, contract research organizations which
provide relatively less expensive resources and expertise in protein expression are
expected to grow at the highest CAGR.
Based on geography, the global Protein Expression Market is segmented into Asia,
Europe, North America, and Rest of the World (RoW). The Asia segment includes the regional
segments of China, India, Japan, and Rest of Asia (RoA). The Europe segment is further
divided into the regional segments of France, Germany, Italy, Spain, the U.K., and the
Rest of Europe (RoE). North America is further divided into regional segments of Canada
and U.S. The Rest of the World (RoW) segment is further divided into the regional segments
of Latin America, Middle East and Africa, and Pacific countries.
The global Protein Expression Market is expected to grow at a CAGR of 8.83% between
2013 and 2018, to reach $1,396.68 million in 2018. Protein expression is an integral part
of proteomics that facilitates research by allowing the expression of genetically
engineered recombinant proteins in a diverse range of host cells. On account of the
decreasing R&D productivity and the patent cliff sales drop, increasing research intensity
in the pharmaceutical sector will be an important growth driver for this market during the
forecast period between 2013 and 2018. In addition, the growth in the biologics and
proteomics market will enhance the research in protein expression, thus enabling it to be
a major growth driver. However, the decline in R&D expenditure and the high consolidation
in the market are restraining the protein expression market.
The major players in the protein expression market are Agilent Technologies, Inc.
(U.S.), Bio-Rad Laboratories (U.S.), Life Technologies Corporation (U.S.), Merck Millipore
(U.S.), New England Biolabs, Inc. (U.S.), Promega Corporation (U.S.), QIAGEN
(Netherlands), Sigma-Aldrich Corporation (U.S.), Takara Bio, Inc. (Japan), and Thermo
Fischer Scientific, Inc. (U.S.).
Browse related reports
Gene Expression Analysis Market by Technology (DNA Microarray, Real-Time PCR, Next
Generation Sequencing), Consumables (DNA Chips, Reagents), Services (Gene Profiling,
Bioinformatics, Data Analysis Software) & Applications] – Global Forecast to 2018
Protein Crystallization & Crystallography Market by Technology (Ion-Exchange
Chromatography, HPLC, Gel-Electrophoresis, NMR, X-Ray Crystallography), Products (Reagents
& Instruments) & End-Users (Pharmaceutical & Biotechnology Companies) – Forecast to 2018
MarketsandMarkets is a global market research and consulting company based in the U.S.
We publish strategically analyzed market research reports and serve as a business
intelligence partner to Fortune 500 companies across the world.
MarketsandMarkets also provides multi-client reports, company profiles, databases, and
custom research services. MarketsandMarkets covers thirteen industry verticals; including
advanced materials, automotives and transportation, banking and financial services,
biotechnology, healthcare information technology, chemicals, consumer goods,
telecommunications and IT, energy and power, food and beverages, industrial automation,
medical devices, pharmaceuticals, agriculture industry, semiconductor and electronics,
aerospace & defense.
We at MarketsandMarkets are inspired to help our clients grow by providing apt
business insight with our huge market intelligence repository.
North – Dominion Plaza
17304 Preston Road
Suite 800, Dallas, TX 75252
Visit MarketsandMarkets Blog @
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets